Development of 3T Magnetic Resonance Research Methods for NIA Studies
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01324206|
Recruitment Status : Recruiting
First Posted : March 28, 2011
Last Update Posted : April 4, 2018
- Magnetic resonance imaging (MRI) studies provide important information on the structure and function of various body systems, including the brain, muscles, joints, heart, and blood vessels. Scientific applications of MRI scans often use techniques that need to be modified or refined before they are used in clinical studies. To develop and modify these techniques for the new Philips 3T Achieva whole-body MRI scanner, researchers are interested in conducting trial MRI scans on healthy individuals and individuals with conditions that require imaging studies.
- To conduct preliminary trials of the 3T MRI facility to develop and refine MRI scanning procedures.
- Individuals at least 18 years of age who are able to have magnetic resonance imaging.
- Participants will be screened with a full medical history and physical examination, as well as blood and urine tests.
- Participants will have an MRI scan using the 3T scanner. Some scans may require the use of a contrast agent or radiotracer, which is a small amount of radioactive substance that will be injected before the start of the scan. Some participants may be asked to perform tasks of thinking and movement while in the scanner, in order to test the procedures required for a functional MRI scan.
- No treatment will be provided as part of this protocol.
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||500 participants|
|Official Title:||Development of 3T Magnetic Resonance Research Methods for NIA Studies|
|Study Start Date :||August 5, 2008|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01324206
|Contact: Denise L Melvin, R.N.||(410) email@example.com|
|Contact: Richard G Spencer, M.D.||(410) firstname.lastname@example.org|
|United States, Maryland|
|National Institute of Aging, Clinical Research Unit||Recruiting|
|Baltimore, Maryland, United States, 21224|
|Contact: NIA Studies Recruitment 410-350-3941 email@example.com|
|Principal Investigator:||Richard G Spencer, M.D.||National Institute on Aging (NIA)|